C. Andréjak

Centre Hospitalier Universitaire Amiens-Picardie

Also affiliated with Agents infectieux, résistance et chimiothérapie, Université de Picardie Jules Verne

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline”.

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Clinical Infectious Diseases(2020)10.1093/cid/ciaa241

N/A

1.0DataRank · unranked

800 citations

Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak +16 more

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1125

N/A

0.993DataRank · unranked

750 citations

Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak +16 more

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

European Respiratory Journal(2020)10.1183/13993003.00535-2020

N/A

0DataRank · unranked

907 citations

Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak +16 more